Artemisinin-independent inhibitory activity of Artemisia sp. infusions against different Plasmodium stages including relapse-causing hypnozoites

Authors:

Abstract
Artemisinin-based combination therapies (ACT) are the frontline treatments against malaria worldwide. Recently the use of traditional infusions from Artemisia annua (from which artemisinin is obtained) or Artemisia afra (lacking artemisinin) has been controversially advocated. Such unregulated plant-based remedies are strongly discouraged as they might constitute sub-optimal therapies and promote drug resistance. Here, we conducted the first comparative study of the anti-malarial effects of both plant infusions in vitro against the asexual erythrocytic stages of Plasmodium falciparum and the pre-erythrocytic (i.e., liver) stages of various Plasmodium species. Low concentrations of either infusion accounted for significant inhibitory activities across every parasite species and stage studied. We show that these antiplasmodial effects were essentially artemisinin-independent and were additionally monitored by observations of the parasite apicoplast and mitochondrion. In particular, the infusions significantly incapacitated sporozoites, and for Plasmodium vivax and P. cynomolgi, disrupted the hypnozoites. This provides the first indication that compounds other than 8-aminoquinolines could be effective antimalarials against relapsing parasites. These observations advocate for further screening to uncover urgently needed novel antimalarial lead compounds.
All Related Versions
Funding Information
  • Labex ParaFrap-IRD PhD South program (ANR-11-LABX-0024)
  • Fondation pour la Recherche Médicale (M19LRUN001)
  • Agence Nationale de la Recherche (M18JRAR023)
  • Fondation pour la Recherche Médicale (EQU202103012700)
  • Agence Nationale de la Recherche (ANR-21-CE44-0010-01)
  • Finovi program (Project Apicolipid)
  • Laboratoire d’Excellence ParaFrap (ANR-11-LABX-0024)
  • LIA-IRP CNRS Program (Project Apicolipid)
  • CEFIPRA-MESRI (6003-1)
  • Agence Nationale de la Recherche (ANR-17-CE13-0025-01)
  • Programme d’Investissements d’Avenir (ANR-11-INBS-0008)
  • Maison de l’Artémisia (N/A)
  • Région Auvergne Rhone-Alpes, AuRA (IRICE GEMELI)
  • Agence Nationale pour la Recherche (ANR-10-IAIHU)
  • Institut Thématique Multi-Organismes ITMO I3M (N/A)
  • Agence Nationale pour la Recherche (ANR-11-INSB-NeurATRIS)

This publication has 27 references indexed in Scilit: